Inspire Medical Systems, Inc. INSP
1 trading plan running, 8 Form 144 notices for $654K
10-Q, 10-K and Form 144What INSP's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Aug 31, 2023 to Apr 10, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in |
|---|---|---|---|
| John Rondoni Chief Product and Innovation Officer |
Adopted 10b5-1 plan | May 22, 2026 | 10-Q Aug 3, 2026 |
| Shawn T McCormick Director |
Adopted 10b5-1 plan | Aug 29, 2025 | 10-Q Nov 3, 2025 |
| John Rondoni Chief Product and Innovation Officer |
Ended 10b5-1 plan | May 13, 2025 | 10-Q Aug 4, 2025 |
| Bryan Phillips General Counsel |
Adopted 10b5-1 plan | Nov 27, 2024 | 10-K Feb 10, 2025 |
| Randall Ban EVP Patient Access and Therapy Development |
Adopted 10b5-1 plan | Nov 13, 2024 | 10-K Feb 10, 2025 |
| Richard J. Buchholz Chief Financial Officer |
Adopted 10b5-1 plan | Nov 13, 2024 | 10-K Feb 10, 2025 |
| Shawn T McCormick Director |
Ended 10b5-1 plan | Nov 1, 2024 | 10-K Feb 10, 2025 |
| Georgia Melenikiotou Director |
Adopted 10b5-1 plan | Aug 30, 2024 | 10-Q Nov 4, 2024 |
| Shawn T McCormick Director |
Adopted 10b5-1 plan | May 24, 2024 | 10-Q Aug 6, 2024 |
| John C. Rondoni Chief Technology Officer |
Adopted 10b5-1 plan | May 23, 2024 | 10-Q Aug 6, 2024 |
| Randall A. Ban Chief Commercial Officer |
Adopted 10b5-1 plan | May 16, 2024 | 10-Q Aug 6, 2024 |
| Jerry Griffin, M.D. Director |
Ended 10b5-1 plan | Nov 30, 2023 | 10-K Feb 9, 2024 |
| John C. Rondoni Chief Technology Officer |
Ended 10b5-1 plan | Nov 23, 2023 | 10-K Feb 9, 2024 |
| Richard J. Buchholz Chief Financial Officer |
Adopted 10b5-1 plan | Aug 31, 2023 | 10-Q Nov 7, 2023 |
| Georgia Garinois-Melenikiotou Director |
Adopted plan | Aug 29, 2023 | 10-Q Nov 7, 2023 |
| Timothy P. Herbert Chief Executive Officer |
Adopted plan | Aug 28, 2023 | 10-Q Nov 7, 2023 |
| Steven Jandrich Vice President, Human Resources |
Adopted 10b5-1 plan | Aug 17, 2023 | 10-Q Nov 7, 2023 |
| Randall Ban Chief Commercialization Officer |
Adopted 10b5-1 plan | Aug 15, 2023 | 10-Q Nov 7, 2023 |
| Philip J. Ebeling Chief Operating Officer |
Adopted 10b5-1 plan | Aug 10, 2023 | 10-Q Nov 7, 2023 |
| John C. Rondoni Chief Technology Officer |
Adopted 10b5-1 plan | May 19, 2023 | 10-Q Aug 1, 2023 |
Show the other 12 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 2, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Aug 24, 2026 | JOHN RONDONI Officer |
64 | $4K |
| Aug 7, 2026 | JASON P KELLY Officer |
963 | $57K |
| May 15, 2026 | JOHN RONDONI Officer |
2,641 | $114K |
| May 14, 2026 | JOHN RONDONI Officer |
700 | $30K |
| May 8, 2026 | SHAWN T MCCORMICK Director |
696 | $32K |
| Jan 9, 2026 | JOHN RONDONI Officer |
109 | $10K |
| Dec 2, 2025 | SHAWN T MCCORMICK Director |
1,200 | $152K |
| Nov 28, 2025 | SHAWN T MCCORMICK Director |
2,000 | $255K |
From the Form 144 XML filed with the SEC, since Nov 28, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/INSP/export.csv") into a cell.